UnityPoint Health Ventures

UnityPoint Health Ventures is the corporate venture capital arm of UnityPoint Health, founded in 2019 and based in West Des Moines, Iowa. It invests in early-stage companies across healthcare, digital therapeutics, health information technology, tech-enabled services, medical devices, and diagnostics to support ideas and partnerships that improve the patient and provider experience and align with UnityPoint Health's mission.

16 past transactions

TailorMed

Series B in 2024
TailorMed Medical Ltd., established in 2017 and based in Tel Aviv, Israel, specializes in health IT solutions. The company develops and provides financial navigation technology and systems, designed to streamline and automate financial processes for both patients and healthcare providers. Their offerings include TailorMed Financial Navigation, a platform to manage and automate financial processes; TailorMed Financial Insights, an analytics and reporting dashboard to track and measure key performance indicators; and TailorMed Pharmacy, a platform to simplify drug ordering, tracking, and billing based on patient treatment regimens.

OpenLoop Health

Series A in 2023
OpenLoop Health provides a comprehensive digital health infrastructure for its clients in the healthcare industry. Its platform offers tech solutions along with clinicians, labs, medications, regulatory support, patient assistance, and other services to facilitate efficient healthcare delivery.

Cardiosense

Series A in 2022
Cardiosense is a company that focuses on developing a physiological waveform AI platform aimed at creating predictive biomarkers for disease detection and treatment. By mining raw biosignals, Cardiosense provides enhanced visibility into cardiac functions and employs advanced signal processing techniques to identify pre-symptomatic markers of cardiac disease. The company specializes in utilizing non-invasive sensors and proprietary algorithms, which allow healthcare professionals to monitor and analyze cardiac health signals effectively. This innovative approach enables the early detection of diseases, thereby facilitating improved patient care and health tracking.

Pathware

Series A in 2022
Pathware is a technology company developing a digital pathology platform for point-of-care diagnostics. The platform combines computational microscopy and artificial intelligence to analyze tissue samples, enabling clinicians and pathologists to diagnose and treat diseases earlier and more precisely, with the goal of improving patient outcomes and reducing diagnostic times. Its product set includes Bioptic, an automated point-of-care biopsy assessment system, along with a sample testing platform and a sample management platform designed to streamline pathology workflows. Founded in 2017 and based in Ann Arbor, Michigan, with an additional location in Seattle, Pathware focuses on bringing computational pathology tools to the bedside to support faster, more accurate decision making in healthcare.

Prolucent Health

Series A in 2021
Prolucent Health offers technology-driven solutions for modern workforce management in healthcare. Its platform employs artificial intelligence and advanced analytics to optimize labor needs, streamline recruitment processes, enhance workforce utilization, and reduce costs.

b.well Connected Health

Series B in 2021
b.well Connected Health, Inc. is a healthcare technology company based in Baltimore, Maryland, with an additional office in Austin, Texas. Founded in 2015, the company has developed an application that aggregates and analyzes consumers' healthcare data, enabling users to store, manage, and share medical records and family health history in one accessible platform. The application provides insights into financial aspects of healthcare, including benefit plan details, co-pays, and deductibles, while also integrating data from wearables and other health applications to monitor aspects such as sleep, fitness, and nutrition. b.well Connected Health primarily serves health plans, health systems, employers, and pharmaceutical companies, offering an integrated solution for consumer engagement, holistic health management, and cost containment, ultimately empowering users to optimize their healthcare experience.

TailorMed

Venture Round in 2021
TailorMed Medical Ltd., established in 2017 and based in Tel Aviv, Israel, specializes in health IT solutions. The company develops and provides financial navigation technology and systems, designed to streamline and automate financial processes for both patients and healthcare providers. Their offerings include TailorMed Financial Navigation, a platform to manage and automate financial processes; TailorMed Financial Insights, an analytics and reporting dashboard to track and measure key performance indicators; and TailorMed Pharmacy, a platform to simplify drug ordering, tracking, and billing based on patient treatment regimens.

DocStation

Seed Round in 2021
DocStation, Inc. is a cloud-based patient care platform headquartered in Austin, Texas, that was established in 2017. The company focuses on connecting payers and pharmacists to facilitate value-based care programs, which aim to reduce healthcare costs and enhance patient outcomes. Its platform equips pharmacists with essential tools, including a comprehensive dashboard that consolidates patient information such as diagnoses, medications, immunizations, allergies, and adverse events. This integration allows pharmacists to create care plans, set goals, monitor patient adherence, and schedule follow-ups, thereby enabling real-time connections with patients. With over 500 providers collaborating with innovative health plans on the platform, DocStation is positioned to transform the pharmacy landscape by aligning the interests of all stakeholders involved in patient care.

SilverCloud Health

Series B in 2020
SilverCloud Health, established in 2011, is a digital health company that develops and provides online therapeutic solutions via tailored clinical programs. Headquartered in Boston, Massachusetts, with offices in Dublin, Ireland, and London, UK, the company's SilverCloud platform offers evidence-based, supported digital therapies to various healthcare sectors. It aims to increase client/patient engagement and reduce program dropout rates, as demonstrated by a three-fold improvement in these metrics compared to leading online therapeutic products.

Bright.md

Series C in 2020
Bright.md Inc. is a healthcare technology company based in Portland, Oregon, focused on developing software solutions for the diagnosis and treatment of low-acuity medical conditions. The company offers SmartExam, an AI-powered virtual care platform that enables patients to receive online care for common health concerns without the need for video consultations. By partnering with leading healthcare organizations, Bright.md provides access to its services for over 10 million patients seeking urgent and primary care from their own devices. The platform facilitates efficient care navigation, triage, and treatment options, allowing patients to address their health needs asynchronously and conveniently. Founded in 2012 as Bright Health Solutions LLC, the company aims to modernize telehealth services for healthcare systems, effectively creating a virtual front door for patient care.

VIDA

Series C in 2020
VIDA is a health technology company delivering AI-enabled imaging and data intelligence to improve respiratory care and accelerate drug development. Its platform supports clinicians in managing patients with chronic lung conditions such as COPD, interstitial lung disease, and lung cancer, as well as responses to emerging respiratory diseases. By combining quantitative data analytics with visualizations, VIDA helps improve care coordination, patient outcomes, and operational efficiency. The company also provides imaging services and integrated clinical data to support pharmaceutical research, enabling faster study enrollment, more precise biomarker targeting, and improved trial outcomes. VIDA’s software has regulatory clearances for clinical use in key markets, including FDA clearance, CE marking, Health Canada licensing, and TGA registration across the US, EU, Canada, and Australia. The business aims to bridge clinical care and life sciences by offering software that supports both patient management and research activities.

b.well Connected Health

Series A in 2020
b.well Connected Health, Inc. is a healthcare technology company based in Baltimore, Maryland, with an additional office in Austin, Texas. Founded in 2015, the company has developed an application that aggregates and analyzes consumers' healthcare data, enabling users to store, manage, and share medical records and family health history in one accessible platform. The application provides insights into financial aspects of healthcare, including benefit plan details, co-pays, and deductibles, while also integrating data from wearables and other health applications to monitor aspects such as sleep, fitness, and nutrition. b.well Connected Health primarily serves health plans, health systems, employers, and pharmaceutical companies, offering an integrated solution for consumer engagement, holistic health management, and cost containment, ultimately empowering users to optimize their healthcare experience.

CareSignal

Venture Round in 2020
CareSignal is a remote patient monitoring platform designed to enhance the performance of payers and providers in value-based care by focusing on patient engagement and early risk identification. The platform utilizes device-less technology to reach large patient populations through disease-specific, evidence-based automated communications, including text messages and phone calls. It enables care teams to receive real-time alerts that facilitate timely prioritization and proactive outreach. CareSignal is particularly committed to supporting underserved populations and safety-net providers, ensuring that patients can interact with the system using their existing phones. This approach helps care teams address chronic, behavioral, and social challenges faced by patients, promoting better health outcomes.

Kaizen Health

Series B in 2020
Founded in 2015, Kaizen Health develops a web-based platform that connects healthcare providers with transportation services. Serving healthcare systems, payers, senior living segments, and more, the company aims to improve access, quality, and efficiency in healthcare by removing transportation barriers.

CareSignal

Seed Round in 2019
CareSignal is a remote patient monitoring platform designed to enhance the performance of payers and providers in value-based care by focusing on patient engagement and early risk identification. The platform utilizes device-less technology to reach large patient populations through disease-specific, evidence-based automated communications, including text messages and phone calls. It enables care teams to receive real-time alerts that facilitate timely prioritization and proactive outreach. CareSignal is particularly committed to supporting underserved populations and safety-net providers, ensuring that patients can interact with the system using their existing phones. This approach helps care teams address chronic, behavioral, and social challenges faced by patients, promoting better health outcomes.

VIDA

Corporate Round in 2019
VIDA is a health technology company delivering AI-enabled imaging and data intelligence to improve respiratory care and accelerate drug development. Its platform supports clinicians in managing patients with chronic lung conditions such as COPD, interstitial lung disease, and lung cancer, as well as responses to emerging respiratory diseases. By combining quantitative data analytics with visualizations, VIDA helps improve care coordination, patient outcomes, and operational efficiency. The company also provides imaging services and integrated clinical data to support pharmaceutical research, enabling faster study enrollment, more precise biomarker targeting, and improved trial outcomes. VIDA’s software has regulatory clearances for clinical use in key markets, including FDA clearance, CE marking, Health Canada licensing, and TGA registration across the US, EU, Canada, and Australia. The business aims to bridge clinical care and life sciences by offering software that supports both patient management and research activities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.